3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Dermatologic
1
Conditions
Sarcoma
19
Neoplasms
7
Osteosarcoma
5
Gastrointestinal Stromal Tumors
4
Neuroblastoma
3
Melanoma
3
Uterine Cervical Neoplasms
2
Testicular Neoplasms
2
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Lymphoma
2
Lung Neoplasms
2
Glioma
2
Esophageal Neoplasms
2
Desmoid Tumors
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Brain Neoplasms
2
Wilms Tumor
1
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Somatostatinoma
1
Skin Neoplasms
1
Sarcoma, Myeloid
1
Sarcoma, Ewing
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neoplastic Cells, Circulating
1
Interventions
Nivolumab
6
Imatinib Mesylate
4
Ipilimumab
3
Cetuximab
3
pembrolizumab
2
palbociclib
2
Specimen Handling
2
Radiotherapy
2
Radiosurgery
2
Protons
2
Proton Therapy
2
Pemetrexed
2
Magnetic Resonance Spectroscopy
2
Cyclophosphamide
2
tazemetostat
1
spartalizumab
1
relatlimab
1
nilotinib
1
camrelizumab
1
avelumab
1
atezolizumab
1
apatinib
1
Zoledronic Acid
1
X-Rays
1
Tiragolumab
1
Thiotepa
1
Surveys and Questionnaires
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Photochemotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chordoma
×
Blood Specimen Collection
×
Sarcoma
×
Clear all
NCT01046487
2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1
Completed
26 enrolled